BamSEC and AlphaSense Join Forces
Learn More

Adial Pharmaceuticals Inc

NASDAQ: ADIL    
Share price (1/8/25): $1.02    
Market cap (1/8/25): $6.534 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages State of Delaware Secretary of State Division of Corporations Delivered 08:03 Am 08/03/2023 Filed 08:03 Am 08/03/2023 Sr 20233153666 - File Number 6439279 Certificate of Amendment of Certificate of Incorporation of Adial Pharmaceuticals, Inc
12/34/56
EX-3.3
from 10-K 26 pages Amended and Restated Bylaws of Adial Pharmaceuticals, Inc
12/34/56
EX-3.12
from S-1/A 2 pages First Amendment to the Second Amended and Restated Operating Agreement of Adial Pharmaceuticals, L.L.C
12/34/56
EX-3.11
from S-1/A 6 pages Agreement and Plan of Merger and Reorganization of Apl Conversion Corp., a Virginia Corporation and Adial Pharmaceuticals, Inc. a Delaware Corporation
12/34/56
EX-3.10
from S-1/A 4 pages Articles of Merger of Apl Conversion Corp. Into Adial Pharmaceuticals, Inc
12/34/56
EX-3.9
from S-1/A 1 page State of Delaware Certificate of Merger of Foreign Corporation Into Domestic Corporation
12/34/56
EX-3.8
from S-1/A 6 pages Terms and Conditions of the Plan of Entity Conversion Adial Pharmaceuticals, L.L.C. Into Apl Conversion Corp. September 26, 2017
12/34/56
EX-3.7
from S-1/A 2 pages Articles of Entity Conversion of Adial Pharmaceuticals, L.L.C
12/34/56
EX-3.6
from S-1/A 7 pages Bylaws of Apl Conversion Corp
12/34/56
EX-3.5
from S-1/A 3 pages Articles of Incorporation of Apl Conversion Corp. a Virginia Stock Corporation
12/34/56
EX-3.4
from S-1/A 20 pages Bylaws of Adial Pharmaceuticals, Inc
12/34/56
EX-3.3
from S-1/A 5 pages Certificate of Incorporation of Adial Pharmaceuticals, Inc
12/34/56
EX-3.11
from S-1 7 pages Agreement and Plan of Reorganization
12/34/56
EX-3.10
from S-1 3 pages Articles of Merger of Apl Conversion Corp. Into Adial Pharmaceuticals, Inc
12/34/56
EX-3.9
from S-1 1 page State of Delaware Certificate of Merger of Foreign Corporation Into Domestic Corporation
12/34/56
EX-3.8
from S-1 4 pages Terms and Conditions of the Plan of Entity Conversion Adial Pharmaceuticals, L.L.C. Into Apl Conversion Corp. , 2017
12/34/56
EX-3.7
from S-1 1 page Articles of Entity Conversion of Adial Pharmaceuticals, L.L.C
12/34/56
EX-3.6
from S-1 6 pages Bylaws of Apl Conversion Corp
12/34/56
EX-3.5
from S-1 3 pages I. in the Event of a Merger, Acquisition, Reorganization or Conversion of the Corporation in Order to Effect a Public Listing of the Corporation’s Securities, Each Series of Common Stock Will Be Treated Identically on a Per Share Basis as Is Each Share of Common Stock Series 1. B. Preferred Stock. I. There Shall Be Two Series of Preferred Stock—series 1 and 2— Authorized for Issuance With the Series Designated at Time of Issuance. the Number of Authorized Shares for Each Series Is Set Forth Below
12/34/56
EX-3.4
from S-1 27 pages Bylaws of Adial Pharmaceuticals, Inc
12/34/56